Company / Interest Expense per Share
Alaunos Therapeutics, Inc. Interest Expense per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.19
FY2024
5-year range
$0.01 / $1.19
FY2021-FY2024
Trend
+503.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +503% YoY in FY2024, a notable deviation from the 3-year average annual change of +1326%.
Based on SEC 10-K filings.
1.19 in FY2024 with a 3-year CAGR of +496.5%.
Increased from $0.01 to $1.19 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +496.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, interest expense per share increased 503.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.19 | +503.0% |
| FY2023 | $0.20 | +3477.1% |
| FY2022 | $0.01 | -1.6% |
| FY2021 | $0.01 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2013 | - | - |
| FY2012 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026